Designing for Dignity: nymble Wins International Federation on Ageing Innovation Prize for Advancing Obesity Care in Older Adults
We’re proud to share that nymble has won the International Federation on Ageing’s Innovating for Impact challenge for advancing obesity care in older adults. Most digital health tools weren’t built with older adults in mind. Through nymbleSilver, delivered entirely via SMS and WhatsApp, we’re removing digital barriers and meeting people where they already are - because accessibility isn’t a feature. It’s foundational.
Building for the Long Term: A year at nymble
As 2025 comes to a close, we reflect on a defining year for nymble - bringing accessible behavioural support to thousands across three countries, launching core platform capabilities, and grounding our mission in a simple truth: real-world healthcare impact requires simplicity, trust, and meeting people where they are.
The WHO Has Entered the Obesity Ring With New GLP-1 Guidelines
The WHO has released its first global guideline on GLP-1 therapies for obesity — finally treating obesity as a chronic disease requiring long-term, integrated care. It marks a pivotal shift: medications are necessary but not enough, behavioural support must be sustained, and real-world data will shape the future of obesity care globally.
From Social Feeds to Real Need: The Global GLP-1 Awareness Gap
Awareness of GLP-1 medications is rising online, but it’s far from universal. In many countries, most people don’t even know these treatments exist—making care feel out of reach. nymble closes that gap with clear, clinically grounded support delivered through SMS and WhatsApp, in people’s own language. No apps, no barriers—just trustworthy guidance that meets people where they are.
Maybe It’s Not Just in Your Genes - How Everyday Behaviours Could Enhance Predictive Response to Obesity Treatment
For decades, obesity care has focused on biology—genes, hormones, and lab values—while overlooking the behaviours that drive real outcomes. What if the strongest predictors of success aren’t in our DNA, but in our daily decisions? At nymble, we’re using conversational and behavioural data to uncover new “digital phenotypes” that predict treatment response and guide more personalized, compassionate obesity care.
Introducing nymble engage: Building the Bridge Between Compliance and Innovation in Patient Support
Across life sciences, there’s excitement for modern PSP technology - and caution about adopting generative AI too quickly. nymble engage bridges that gap, delivering compliant behavioural support through familiar messaging channels and a safe, structured pathway for organizations to embrace AI-powered innovation on their own terms.
Access by Design: Why the Last Mile of Obesity Care Can’t Be Another App
True access means inclusivity - reaching people of every age, income, and background through the tools they already use. Obesity care doesn’t need another app. It needs infrastructure designed for everyone.
The Clinical Confidante: How GenAI Increases Self-Disclosure to Improve Obesity Care
The idea of a clinical confidante recognizes that computer interactions facilitate greater intimate self-disclosure under conditions of perceived anonymity. As an automated patient support program, nymble embodies the clinical confidante concept.
Shifting Focus in Weight Management: From Dreams to Reality
Managing metabolic health is about more than discipline—it’s shaped by biology, environment, and life’s challenges. This blog draws on insights from the OBSERVE study and real stories from the nymble community, showing how progress often means celebrating non-scale victories and setting goals that fit real life. Because true health isn’t just about losing weight—it’s about living better.